Position in VRTX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$2,941,805
-$53,091 QoQ
Shares Held
6,588
-0.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHANNEL WEALTH LLC holds $6,129,325 across 2 Biotechnology names. VRTX ranks #2 (48.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
97,957 | $3,187,520 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
6,588 | $2,941,805 |
All Filings in VRTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,941,805 | 6,588 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,994,896 | 6,606 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $4,135,326 | 10,559 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $6,178,040 | 13,877 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $990,972 | 2,044 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $716,000 | 1,778 | Shares | Sole | 2025-01-15 | |
| No filing history on record for this holder in this stock. | ||||||